Annual Oration in Radiation Oncology Presented Today
Wednesday, Dec. 02, 2015
Walter J. Curran Jr., M.D. will present the 2015 Annual Oration in Radiation Oncology, "NRG Oncology and the National Cancer Institute's National Clinical Trials Network: A Case Study for Innovation in Multi-Disciplinary Cancer Research," today in the Arie Crown Theater.
In 2014, after several years of extensive consultation and coordination with many stakeholders, the National Cancer Institute (NCI) transformed its longstanding cooperative group program into the new National Clinical Trials Network (NCTN).
NCTN then created five new groups including NRG Oncology, a non-profit research organization formed to conduct oncologic clinical research and to broadly disseminate study results for informing clinical decision making and healthcare policy, according to Dr. Curran, chair of NRG Oncology.
NRG Oncology brings together the National Surgical Adjuvant Breast and Bowel Project, the Radiation Therapy Oncology Group and the Gynecologic Oncology Group—each recognized internationally as a research leader. The organization focuses its clinical and translational research efforts on patients afflicted with malignant brain tumors, head and neck cancers, lung cancers, breast cancers, gastrointestinal cancers, genitourinary cancers and gynecologic cancers, Dr. Curran says. He will discuss the means by which NRG Oncology develops and executes practice-defining research for these patients on a global basis.
Dr. Curran is the executive director of Winship Cancer Institute of Emory University, Atlanta, and the Georgia Research Alliance Scholar and Chair in Cancer Research. Dr. Curran also serves as the Lawrence W. David Professor and Chairman of the Department of Radiation Oncology at Emory School of Medicine. He served as chairman and principal investigator of the Radiation Therapy Oncology Group, an NCI-funded cooperative group.